Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

  • C. Oakman, L. Tenori, W. M. Claudino, S. Cappadona, S. Nepi, A. Battaglia, P. Bernini, E. Zafarana, E. Saccenti, M. Fornier, P. G. Morris, L. Biganzoli, C. Luchinat, I. Bertini, A. Di Leo
  • Annals of Oncology, January 2011, Oxford University Press (OUP)
  • DOI: 10.1093/annonc/mdq606

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Edoardo Saccenti